Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery

Adv Healthc Mater. 2013 Feb;2(2):281-6. doi: 10.1002/adhm.201200176. Epub 2012 Aug 28.
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Blotting, Western
  • Camptothecin / administration & dosage*
  • Cell Line, Tumor
  • Drug Carriers* / chemistry
  • Folic Acid*
  • Humans
  • In Situ Nick-End Labeling
  • Microscopy, Confocal
  • Nanoparticles*
  • Silicon Dioxide*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Silicon Dioxide
  • Folic Acid
  • Camptothecin